8. Small Molecule Immunopotentiators as Vaccine Adjuvants

  1. Manmohan Singh M. Pharm., Ph.D.
  1. Fengfeng Xu,
  2. Nicholas M. Valiante and
  3. Jeffrey B. Ulmer

Published Online: 2 NOV 2006

DOI: 10.1002/9780470134931.ch8

Vaccine Adjuvants and Delivery Systems

Vaccine Adjuvants and Delivery Systems

How to Cite

Xu, F., Valiante, N. M. and Ulmer, J. B. (2007) Small Molecule Immunopotentiators as Vaccine Adjuvants, in Vaccine Adjuvants and Delivery Systems (ed M. Singh), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470134931.ch8

Editor Information

  1. Novartis Vaccines, Emeryville, California, USA

Author Information

  1. Novartis Vaccines, Emeryville, California, USA

Publication History

  1. Published Online: 2 NOV 2006
  2. Published Print: 15 JUN 2007

ISBN Information

Print ISBN: 9780471739074

Online ISBN: 9780470134931

SEARCH

Keywords:

  • small molecule immunopotentiators (SMIPs) vaccine adjuvants;
  • Toll-like receptors (TLRs) and leucine rich repeat (LRR);
  • innate and adaptive immunity control by TLR signaling

Summary

This chapter contains sections titled:

  • Control of Innate and Adaptive Immunity by TLR Signaling

  • Effects of Smips on Cellular Functions

  • SMIPs as Vaccine Adjuvants

  • Future Outlook

  • Acknowledgments

  • References